In vivo visualization and control of pathological changes in neural circuits

Patent metadata

Field	Value
Publication number	US-11759651-B2
Application number	US-201916677407-A
Country	US
Kind code	B2
Filing date	Nov 7, 2019
Priority date	Sep 9, 2011
Publication date	Sep 19, 2023
Grant date	Sep 19, 2023

Abstract

Neurological Disease Mechanism Analysis for Diagnosis, Drug Screening, (Deep) Brain Stimulation Therapy design and monitoring, Stem Cell Transplantation therapy design and monitoring, Brain Machine Interface design, control, and monitoring.

First claim

The invention claimed is:

1. A method for cell transplantation design for a living organism, the method comprising:
selecting a target cell population including stem cells at various developmental stages and types;
modifying a function of the target cell population by causing cells of the target cell population to express light responsive molecules that can be controlled with targeted light delivery;
transplanting a portion of cells expressing light responsive molecules into a living organism during a cell transplantation;
measuring nervous system responses to targeted energy control using functional magnetic resonance imaging (fMRI), wherein the measuring is conducted via a parallel processing architecture having one or more processors and memory storing instructions defining a plurality of threads for performing respective processes, and the measuring includes:
performing, by a first thread of the plurality of threads, direct circuit current (DC) offset correction;
performing, by a second thread of the plurality of threads, data reconstruction; and
performing, by a third thread of the plurality of threads, data display tasks; and

determining at least one of neural circuit activity locations and neural circuit activity timings in the living organism.

2. The method of claim 1 , further comprising profiling the cells based on differences in measured responses derived from a normal living organism and a diseased living organism to provide a phenotype of disease.

3. The method of claim 1 , wherein a cell transplantation location or type is selected to achieve normal brain function.

4. The method of claim 1 , wherein the targeted energy control is applied at least one time before, during and after the cell transplantation to improve therapeutic outcome.

5. The method of claim 1 , wherein measurements are analyzed for resting connectivity and are used to interpret clinical resting state functional neuroimaging data.

6. The method of claim 1 , wherein the targeted light delivery includes delivering blue light of approximately 470 nm or yellow light of approximately 580 nm.

7. The method of claim 1 , wherein the light responsive molecules include Channelrhodopsin-2 (ChR2) or halorhodopsin (NpHR).

8. The method of claim 1 , wherein the parallel processing architecture includes closed-loop control.

9. The method of claim 1 , wherein the measuring is conducted with a high-resolution using a parallel compressed sensing reconstruction.

10. The method of claim 1 , wherein performing the data reconstruction includes:
performing gridding, then fast-Fourier transforms (FFTs), and then FFT shifts on data obtained from the measuring, wherein the gridding, FFTs, and FFT shifts are performed in parallel on different portions of the data.

11. The method of claim 10 , wherein performing the data reconstruction includes performing motion correction.

12. The method of claim 11 , wherein performing the motion correction includes:
evaluating in parallel a plurality of cost functions; and
optimizing the plurality of cost functions.

13. The method of claim 12 , wherein:
the plurality of cost functions is evaluated in parallel using a graphical processing unit; and
the plurality of cost functions is optimized using a central processing unit.

14. The method of claim 12 , wherein a cost function of the plurality of cost functions comprises a least square error and a correlation ratio.

15. The method of claim 14 , wherein evaluating in parallel the plurality of cost functions includes evaluating the least square error, including:
calculating in parallel a plurality of single voxel errors; and
summing in parallel the plurality of single voxel errors.

16. The method of claim 14 , wherein the correlation ratio comprises a plurality of joint probability distribution functions summed in parallel.

17. The method of claim 10 , wherein performing the gridding comprises:
searching for spiral samples within a plurality of gridding kernels;
convolving the spiral samples found in individuals ones of the plurality of gridding kernels with a weighted kernel function; and
summing results of the convolving from the plurality of gridding kernels.

18. The method of claim 17 , further comprising presorting the spiral samples.

19. The method of claim 17 , wherein the searching for spiral samples for each of the plurality of gridding kernels is performed in parallel by separate threads of a processor.

Assignees

• Univ California

Inventors

• Lee Jin Hyung
• Fang Zhongnan

Classifications

• A61B5/0036 Primary

  including treatment, e.g., using an implantable medical device, ablating, ventilating · CPC title

• A61N5/0622 Primary

  Optical stimulation for exciting neural tissue · CPC title

• A61B5/055

  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging · CPC title

• A61B5/7232

  involving compression of the physiological signal, e.g. to extend the signal recording period · CPC title

• A61B5/0002

  Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network (endoradiosondes A61B5/07) · CPC title